微量胺相关受体 (TAAR) 是一类 G 蛋白偶联受体,于 2001 年被发现。人类拥有六种功能同工型 (TAAR1、TAAR2、TAAR5、TAAR6、TAAR8 和 TAAR9),而一些鱼类物种表达超过 100 种。它充当微量胺的内源性受体。微量胺是内源性化合物,传统上被认为包含 β-苯乙胺、对酪胺、色胺、对章胺及其一些代谢物。
尽管所有其他 TAAR 主要或专门用作主要嗅觉系统中的化学感应受体,但已证明 TAAR 1 是大脑中多巴胺、血清素和谷氨酸活性的新型调节剂。TAAR 1 已被确定为精神分裂症、抑郁症和成瘾症的新治疗靶点。在外周,TAAR1 调节营养诱导的激素分泌,表明其有可能成为糖尿病和肥胖症的新治疗靶点。TAAR1 还可以通过调节白细胞分化和活化来调节免疫反应。
Trace amine associated-receptors (TAARs) are a class of G protein-coupled receptors that were discovered in 2001. Humans possess six functional isoforms (TAAR1, TAAR2, TAAR5, TAAR6, TAAR8, and TAAR9), whereas some fish species express over 100. It acts as an endogenous receptor for the trace amines. Trace amines are endogenous compounds classically regarded as comprising β-phenylethyalmine, p-tyramine, tryptamine, p-octopamine, and some of their metabolites.
Although all other TAARs serve predominantly or exclusively as chemosensory receptors in the main olfactory system, TAAR 1 has been demonstrated to be a novel modulator of dopaminergic, serotonergic and glutamatergic activity in the brain. And TAAR 1 has been identified as a novel therapeutic target for schizophrenia, depression, and addiction. In the periphery, TAAR1 regulates nutrient-induced hormone secretion, suggesting its potential as a novel therapeutic target for diabetes and obesity. TAAR1 may also regulate immune responses by regulating leukocyte differentiation and activation.
3-Iodothyronamine (hydrochloride) 是一种内源性速效甲状腺激素衍生物,在体外可有效激活 TAAR1,并在体内快速诱导体温降低,可用于充血性心力衰竭的研究。
ZH8659 hydrochloride 是一种微量胺相关受体 1 (TAAR1)-Gq 激动剂,可用于神经相关疾病的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号